Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine
Conditions: Tetanus; Diphtheria; Pneumococcal Infections Interventions: Biological: Tetanus-diphtheria (Td) and PCV13; Biological: PCV13 alone; Biological: Td alone Sponsor: Korea University Guro Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diphtheria | Hospitals | Meningitis Vaccine | Pneomococcal Vaccine | Tetanus | Tetanus Vaccine | Vaccines